The Federal Drug Administration issued a ruling Tuesday that essentially begins a final review process that will determine whether hospitals can use RFID systems from the Palm Beach, Fla.-based company to identify patients and/or permit relevant hospital staff to access medical records, said Angela Fulcher, vice president of marketing and sales at VeriChip.
VeriChip sells 11-millimeter RFID tags that get implanted in the fatty tissue below the right tricep. When near one of Verichip's scanners, the chip wakes up and radios an ID number to the scanner. If the number matches an ID number in a database, a person with the chip under his or her skin can enter a secured room or complete a financial transaction.
